Molecular Mechanisms of Antidiuretic Effect of Oxytocin
Open Access
- 1 February 2008
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 19 (2) , 225-232
Abstract
Oxytocin is known to have an antidiuretic effect, but the mechanisms underlying this effect are not completely understood. We infused oxytocin by osmotic minipump into vasopressin-deficient Brattleboro rats for five days and observed marked antidiuresis, increased urine osmolality, and increased solute-free water reabsorption. Administration of oxytocin also significantly increased the protein levels of aquaporin-2 (AQP2), phosphorylated AQP2 (p-AQP2), and AQP3 in the inner medulla and in the outer medulla plus cortex. Immunohistochemistry demonstrated increased AQP2 and p-AQP2 expression and trafficking to the apical plasma membrane of principal cells in the collecting duct, and increased AQP3 expression in the basolateral membrane. These oxytocin-induced effects were blocked by treatment with the vasopressin V2 receptor antagonist SR121463B, but not by treatment with the oxytocin receptor antagonist GW796679X. We conclude that vasopressin V2 receptors mediate the antidiuretic effects of oxytocin, including increased expression and apical trafficking of AQP2, p-AQP2, and increased AQP3 protein expression.Keywords
This publication has 19 references indexed in Scilit:
- Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for HyponatremiaNew England Journal of Medicine, 2006
- 2,5-Diketopiperazines as Potent, Selective, and Orally Bioavailable Oxytocin Antagonists. 3. Synthesis, Pharmacokinetics, and in Vivo PotencyJournal of Medicinal Chemistry, 2006
- Hyperosmolality In Vivo Upregulates Aquaporin 2 Water Channel and Na-K-2Cl Co-Transporter in Brattleboro RatsJournal of the American Society of Nephrology, 2006
- α-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstructionAmerican Journal of Physiology-Renal Physiology, 2006
- Aquaporins in the Kidney: From Molecules to MedicinePhysiological Reviews, 2002
- Selective blockade of vasopressin V2 receptors reveals significant V2‐mediated water reabsorption in Brattleboro rats with diabetes insipidusNephrology Dialysis Transplantation, 2001
- Upregulation of aquaporin-2 water channel expression in chronic heart failure rat.Journal of Clinical Investigation, 1997
- Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.Journal of Clinical Investigation, 1996
- Molecular cloning of the receptor for human antidiuretic hormoneNature, 1992
- Antidiuretic effects of oxytocin in the Brattleboro ratCellular and Molecular Life Sciences, 1985